NACE Non-invasive prenatal test

Why use NACE test?

• Prevent the need for 98% of invasive tests in patients at risk for trisomy 21 (Down Syndrome).
• Reduces the number of miscarriages caused by amniocentesis or chorionic villus sampling (CVS).
• Can give results with fetal fraction under 4%.
• NACE has the highest informatively rate in the market: we obtain results for 99% of the analyzed samples.
• More reliable than 1st trimester combined screening. The false positive rates of conventional tests, including biochemical screening, mean that 1 in every 20 women who test positive for Down syndrome will actually be carrying a healthy baby.
• Avoid a false sense of security: Of every 20 women carrying a baby with Down syndrome, 3 will test negative by biochemical screening.
• The new NACE 24 technology allows analysis of aneuploidies (mainly trisomies) as well as deletions and duplications greater than 7Mb. This allows a more detailed investigation of high-risk pregnancies, to identify potentially clinically relevant conditions such as true fetal mosaicism, uniparental disomy and chromosomal imbalances (when the parents are carriers of balanced translocations).